Related Experiment Video
Updated: May 25, 2025

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
[Controllability and predictability of riboflavin-ultraviolet A collagen cross-linking: advances in experimental
Xiaona Liu1, Xiaona Li1, Weiyi Chen1
1Collage of Artificial Intelligence, Taiyuan University of Technology, Taiyuan 030024, P. R. China.
Abstract:
Riboflavin-ultraviolet A (UVA) collagen cross-linking has not only achieved good clinical efficacy in the treatment of corneal diseases such as dilatation keratopathy, bullae keratopathy, infectious keratopathy, and in the combined treatment of corneal refractive surgeries, but also its efficacy and safety in scleral collagen cross-linking have been initially confirmed. To better promote the application of cross-linking in the clinical treatment of corneal and scleral diseases, exploring controllability and predictability of the surgical efficacy are both important for evaluating the surgical efficacy and personalized precision treatment. In this paper, the progress on the cross-linking depth of riboflavin-UVA collagen cross-linking, and its relationship with the cross-linking effect will be reviewed. It will provide the reference for further application of this procedure in ophthalmology clinics.
Related Concept Videos
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...

